12,365 Shares in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Acquired by VCI Wealth Management LLC

VCI Wealth Management LLC acquired a new position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 12,365 shares of the company’s stock, valued at approximately $515,000. VCI Wealth Management LLC owned 0.24% of SPDR S&P Pharmaceuticals ETF as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Envestnet Portfolio Solutions Inc. acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 3rd quarter valued at $1,938,000. LPL Financial LLC lifted its stake in shares of SPDR S&P Pharmaceuticals ETF by 26.4% in the 3rd quarter. LPL Financial LLC now owns 124,782 shares of the company’s stock valued at $4,960,000 after purchasing an additional 26,031 shares during the last quarter. Kingsview Wealth Management LLC acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 3rd quarter valued at $696,000. Ieq Capital LLC acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 3rd quarter valued at $550,000. Finally, Flputnam Investment Management Co. acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 4th quarter valued at $327,000.

SPDR S&P Pharmaceuticals ETF Trading Down 1.0 %

SPDR S&P Pharmaceuticals ETF stock traded down $0.41 on Thursday, reaching $39.09. 47,131 shares of the stock were exchanged, compared to its average volume of 42,935. The stock has a market cap of $191.54 million, a PE ratio of 14.45 and a beta of 0.87. SPDR S&P Pharmaceuticals ETF has a twelve month low of $34.67 and a twelve month high of $45.62. The firm has a fifty day moving average price of $42.61 and a two-hundred day moving average price of $40.58.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.